A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07216469
- Status
- Recruiting
Conditions
- Amyloidosis
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Magnetic Resonance Elastography (MRE) — DIAGNOSTIC_TESTPatients will undergo a cardiac MRI with the addition of continuous free-breathing and breath-held MRE sequences.
Study Details
This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance elastography (MRE) in patients with cardiac amyloidosis.
Key Dates
- Start date
- Oct 14, 2025
- Status verified
- Dec 2025
- Primary completion
- Nov 30, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Cardiac Amyloidosis
Primary Outcome Measure
Percentage of subjects able to complete a Magnetic Resonance Elastography exam [ Time Frame: Baseline ]
Central Contacts
- Kathy Brown507-538-8274
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Ian C Chang, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPHASE3 · Recruiting · Eidos Therapeutics, a BridgeBio company · La Jolla, California
- A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.PHASE1/PHASE2 · Recruiting · Alexion Pharmaceuticals, Inc. · Phoenix, Arizona
- A Study Of MCG In Cardiac AmyloidosisRecruiting · Mayo Clinic · Rochester, Minnesota
- Registry for Adults With Plasma Cell Disorders (PCD's)Recruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina